Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Size: px
Start display at page:

Download "Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter"

Transcription

1 Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

2 Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben als erstes die MIVH Technik bei 30 Patienten durchgeführt unter Verwendung des MiniHarvest System (US Surgical Corporation, Norwalk, Conn) 1996 Lumsden und Kollegen haben als erstes die EVH bei 30 Patienten durchgeführt und beschrieben (Georgia, USA) 1.Tevaearai HT et al. Minimally invasive harvest of the saphenous vein for coronary artery bypass grafting. Ann Thorac Surg. 1997;63(6): Lumsden AB et al. Subcutaneous, veideo-assisted saphenous vein harvest: report of the first 30 cases. Cardiovasc Surg. 1996; 4(6): 771-6

3 EVH Einsatz und Verbreitung in den USA 1 90% 92% 93% 0,8 0,6 65% 70% 76% 55% 82% 62% 71% 73% 76% 46% 0,4 0,2 0 2% 7% 15% 20% 28% 36% * E USER ADOPTION (% of hospitals using EVH) PENETRATION (% of CABG cases using EVH)

4 EVH in den USA und Europa

5 EVH Vorteile vs. OVH Geringeres chirurgisches Trauma Inzisionslänge, Blutverlust, Schmerzen, postoperative Immunfunktion schnellere Rekonvaleszenz geringere postop. Wundheilungsstörungen befriedigenderes kosmetisches Ergebnis (Kostenreduktion) Patientenzufriedenheit

6 EVH vs. OVH Kosmetisches Resultat offen endoskopisch

7 EVH vs. OVH Wundheilung 2-25%

8 EVH Patientenauswahl Keine Adipositas permagna Keine extrem oberflächliche Vena saphena Keine Seitenastvarikosis Keine Gerinnungsauffälligkeiten Keine Notfälle Nur selektiertes Patientengut

9 EVH Nachteile vs. OVH Bypass-Versagen Fehlende Langzeitergebnisse Längere Operationszeiten Kostenerhöhung

10 EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Objective: EVH improves clinical and resource outcomes compared with OVH in adults undergoing CABG Methods: Comprehensive literature search (Medline, Embase ) to identify all randomized and nonrandomized trials of EVH vs. OVH up to April 2005 Primary outcome: wound complications Secondary outrcomes: any other clinical morbidity and resource utilization Results: 36 trials of patients 13 randomized (1.319 patients) 23 nonrandomized (8.313 patients) 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

11 EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Results: Risk of wound complications Risk of wound infections Need for surgical wound intervention significantly reduced by EVH vs. OVH Incidence of pain, neurolgia, patient satisfaction improved with EVH vs. OVH Postop. MI, stroke, reintervention, AP quality of graft not significantly different betw. EVH vs. OVH Operative time significantly increased by EVH 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

12 EVH vs. OVH aktuelle Datenlage 2005 The International Society for Minimally Invasive Cardiac Surgery (ISMICS) Consensus Conference suggest: Innovations 2005 EVH is recommended to reduce wound related complications, improve patient satisfaction, and decrease postop. pain, hospital LOS, and outpatient wound management resources when compared to OVH (Class I; Level A) Based on quality of conduit harvested, either EVH or OVH technique may be used (Class IIa; Level B) Based on major adverse cardiac events and angiographic patency at 6 months, either EVH or OVH technique may be used (Class IIa; Level A) Conclusion: EVH should be considered the standard of care for patients who require saphenous vein grafts for coronary bypass surgery 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

13 EVH vs. OVH aktuelle Datenlage Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery N Engl J Med 2009 Objective: Effect of EVH on vein-graft failure as assessed by angiography 12 to 18 months and on long-term clinical outcomes Methods: patients undergoing CABG (1.753 EVH; 1247 OVH); randomized, 107 centers Primary outcome: vein-graft failure (defined as >75% stenosis of graft on angio.) Clinical outcomes: death, MI, repeat revascularization (3 year follow-up period) Results: EVH significantly higher rates of vein-graft failure at 12 to 18 months than OVH (46.7% vs. 38.0%, P<0.001) EVH associated with higher rates of death, MI, or repeat revascularization after 3 y (20.2% vs. 17.4%, P=0.04) A 4. Lopes RD, Hafley GE, Allen KB et al. Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery: N Engl J Med. 2009; 361(3):

14 EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Objective: Assess the effect of EVH on short-term and midterm outcomes after CABG Ann Thorac Surg 2010 Methods: at a single center (Canada); data prospectively collected patients undergoing first time isolated CABG and combined valve/cabg (34.4%) patients EVH; (65.6%) patients OVH (continuous/bridging) Short-term outcomes: Midterm outcomes: leg infections, in-hospital mortality, all-cause mortality, readmission to hospital for cardiac catheterization, repeat revascularization, unstable angina, MI, heart failure median follow-up 2.6 years 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): A

15 EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Ann Thorac Surg 2010 Results: EVH associated with reduced rates of leg infection (1.1% vs. 2.2%, p=0.003) EVH similar rates of in-hospital mortality compared with OVH (3.2% vs. 4.0%, p=0.16) EVH no association with midterm adverse outcomes (hazard ratio 0.93, p=0.22) EVH and OVH similar freedom from death or readmission to hospital for cardiac cause EVH associated with reduced rate of readmission to hospital for unstable angina (hazard ratio 0.74), but not for MI Conclusion: EVH is not an independent predictor of in-hospital or midterm adverse outcomes 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): 403-8

16 A EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Objective: Explore use of EVH and influence on perioperative and long-term outcomes Circulation 2011 Methods: at a 8 centers (north. New Engl.); data prospectively collected patients undergoing first time isolated CABG (excluded: <30y, emergency surgery, life-threatening malignancy, TAR, radial artery) (52.5%) patients EVH; (47.5%) patients OVH (continuous incision) Short-term outcomes: Long-term outcomes: in-hospital morbidity and mortality mortality and repeat revascularization (CABG or PCI) follow-up 4 years 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

17 EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 mortality Figure 1. Adjusted risk of mortality by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to mortality. Adjusted for age, sex, EF, vascular disease, DM, BMI 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

18 EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 repeat revascularization Figure 2. Adjusted risk of repeat revasculariztaion by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to risk of repeat revascularization. Adjusted for age, sex, EF, vascular disease, DM, BMI, 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

19 EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 Results: In-Hospital outcomes: Use of OVH associated with an increased postop. leg wound infection (P<0.001) EVH associated with an increase in return to operating room for bleeding (P=0.03) Long-Term outcomes: EVH significantly associated with a reduced risk of mortality EVH associated with an insignificant increased risk of repeat revascularization Conclusion: EVH is a safe and viable technique for obtaining saphenous vein conduit for CABG Additional studies are warranted to improve understanding of mechanism by which EVH influences long-term outcomes, as well as how clinical teams can maximize the utility of this technique 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

20 EVH - Schlussfolgerung Sicheres und praktikables Verfahren Datenlage zeigt durchweg geringere Wundkomplikationsraten Sehr gutes kosmetisches Ergebnis erhöhte Patientenzufriedenheit Prospektiv-randomisierte Studien Langzeitergebnisse nach EVH (EVH vs. MIVH) Kostenanalyse

Impact of Endoscopic Versus Open Saphenous Vein Harvest Techniques on Outcomes After Coronary Artery Bypass Grafting

Impact of Endoscopic Versus Open Saphenous Vein Harvest Techniques on Outcomes After Coronary Artery Bypass Grafting SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual

More information

Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison

Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison Radim Brat a, Jaroslav Horacek b, Jiri Sieja a Aims. The aim of this study

More information

Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, an Angiographically Measured Graft Patency Comparison

Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, an Angiographically Measured Graft Patency Comparison Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects 8-14-2010 Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG,

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery Bypass Grafting

Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery Bypass Grafting Medicine with Industrial Specialization Medical Market Access Aalborg University Fall 2011 Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013 Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2

Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2 Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2 RE: The permitted role of unlicensed surgical assistants ( assistants ) in taking of the saphenous vein during coronary artery bypass graft (

More information

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest. Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases

The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest. Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases Authors: Mohammad Hassan NEZAFATI, MD (1) Pouya NEZAFATI

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

The return of myocardial ischemia after coronary artery

The return of myocardial ischemia after coronary artery Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting Joseph F. Sabik III, MD; Eugene H. Blackstone, MD; A. Marc Gillinov, MD; Nicholas G. Smedira, MD; Bruce W. Lytle, MD

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be... In hospital diabetes care background and challenges Duality of interest Nothing to disclose within the framework of this presentation My own fasting BG is 4.6 mmol/l, HbA1c 5.4% Bruce H.R. Wolffenbuttel

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality

Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality Bershinsky, J Matt, PA-C; Bitondo, Jerene M, PA-C; Brennan, Teresa, PA-C, MPAS; Causey, Keith, PA-C; DeMara,

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

PHYSICIAN ASSISTANTS IN CARDIAC SURGERY

PHYSICIAN ASSISTANTS IN CARDIAC SURGERY PHYSICIAN ASSISTANTS IN CARDIAC SURGERY Past,, and Future PAST 1965 first class of Physician Assistants graduated from Duke University Research revealed geographic maldistribution of primary care providers

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore

More information

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Pre-Operative Cardiac Evaluation Kalpana Jain, MD Pre-Operative Cardiac Evaluation Kalpana Jain, MD Cardiac evaluation is an integral part of pre-op evaluation. Perioperative cardiac events are common causes of mortality. Major cardiac complications associated

More information

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

More information

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park MD PhD Seung-Jung Park, MD, PhD, University of Ulsan

More information

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes C. Manlhiot, A. Crean, N. Fernandopulle, B. Lew, N. Chahal, B.W. McCrindle Division of Cardiology, Department of

More information

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed

More information

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA Journal of Pharmacy and Pharmacology 3 (2015) 33-38 doi: 10.17265/2328-2150/2015.01.005 D DAVID PUBLISHING Evaluation of Glycemic Control with a Pharmacist-Managed Post-Cardiothoracic Surgery Insulin Protocol

More information

Non-surgical treatment of severe varicose veins

Non-surgical treatment of severe varicose veins Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in

More information

January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693

January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693 Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693 Clinicopathological comparisons of open vein harvesting

More information

Description of problem Description of proposed amendment Justification for amendment ERG response

Description of problem Description of proposed amendment Justification for amendment ERG response KEY INACCURACIES Issue 1 Distinguishing between groups of STEMI patients Key issue throughout the report The ERG distinguishes between groups of STEMI patients defining four patient groups: STEMI without

More information

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation Original Contribution Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation Cynthia A. Yock, MS, J. Michael Isbill, MS, Spencer B. King III, MD, Mark

More information

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,

More information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data

More information

LEADERS: 5-Year Follow-up

LEADERS: 5-Year Follow-up LEADERS: -Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable Polymer : Final Report of the LEADERS

More information

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial David J. Cohen, Tara A. Lavelle, Patrick W. Serruys, Friedrich

More information

Evidence tabel Lokaal palliatieve behandelingen

Evidence tabel Lokaal palliatieve behandelingen Auteurs, jaartal Mate van bewijs Studie type Follow-up Populatie (incl. steekproef-grootte) Patienten kenmerken Interventie Controle Resultaten Conclusie Opmerkingen, commentaar Hartgrink, 2002 The Netherlands

More information

PCI vs. CABG for Left Main Disease

PCI vs. CABG for Left Main Disease The EXCEL Ti Trial Design, Status, t and Timelines Gregg W. Stone, MD Columbia University Medical Center NewYork-Presbyterian Hospital Cardiovascular Research Foundation PCI vs. CABG for Left Main Disease

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Minimally Invasive Mitral Valve Surgery

Minimally Invasive Mitral Valve Surgery Minimally Invasive Mitral Valve Surgery Stanford Health Care offers leading, superior options in cardiac surgery, including the latest techniques and research for Minimally Invasive Cardiac surgery. Advanced

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN

Michigan Heart & Vascular Institute ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN ON THE ST. JOSEPH MERCY HOSPITAL CAMPUS, ANN ARBOR, MICHIGAN Dear Colleague: Cardiovascular medicine has marked an important milestone in the battle against heart disease. The latest available data indicates

More information

Alexander Chernyavskiy 1, Alexander Volkov 1, Oleg Lavrenyuk 1, Igor Terekhov 1 and Yulia Kareva 1,2*

Alexander Chernyavskiy 1, Alexander Volkov 1, Oleg Lavrenyuk 1, Igor Terekhov 1 and Yulia Kareva 1,2* Chernyavskiy et al. Journal of Cardiothoracic Surgery (2015) 10:163 DOI 10.1186/s13019-015-0353-3 RESEARCH ARTICLE Comparative results of endoscopic and open methods of vein harvesting for coronary artery

More information

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,

More information

Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu

Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu 1 Health care quality and transparency of care and outcomes AHRQ s IQI and PSIs State initiatives Multiple

More information

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Preoperative drainage is always indicated in malignant CBD strictures PRO Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Background Jaundice is associated with high perioperative morbidity

More information

Surgical Site Infection Prevention

Surgical Site Infection Prevention Surgical Site Infection Prevention 1 Objectives 1. Discuss risk factors for SSI 2. Describe evidence-based best practices for SSI prevention 3. State principles of antibiotic prophylaxis 4. Discuss novel

More information

Laparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds

Laparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds Laparoscopic Repair of Incisional Hernia Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds Overview Definition Advantages of Laparoscopic Repair Disadvantages of Open Repair

More information

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke

More information

Medical Translusion and Endoscopic Vein Harvesting - A Review

Medical Translusion and Endoscopic Vein Harvesting - A Review CLINICAL AND MOLECULAR EFFECTS OF ENDOSCOPIC VEIN HARVESTING A thesis submitted to the University of Manchester for the degree of MPhil in the Faculty of Medical and Human Sciences. 2013 Bhuvaneswari Krishnamoorthy

More information

A Master class in Conduit surgery for CABG

A Master class in Conduit surgery for CABG Course Directors: Mr. Simon Kendal A Master class in Conduit surgery for CABG Mr. Michael Lewis Mr. R. Shah Mrs. B Krishnamoorthy SCTS Education Secretary: Mr. Michael E Lewis 3 rd of November 2014 Manchester

More information

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from

More information

Managing the lower limb in coronary artery bypass grafting

Managing the lower limb in coronary artery bypass grafting Managing the lower limb in coronary artery bypass grafting Wounds International, Vol 1, Issue 5 Practice Managing the lower limb in coronary artery bypass grafting Coronary artery bypass grafting (CABG)

More information

Appendix G - Identification and Selection of Studies

Appendix G - Identification and Selection of Studies FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies

More information

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required Welcome! This document contains three (3) series of Case Study examples that will demonstrate all four OHSU reporting categories (#1 4) as well as examples of events that are considered not reportable.

More information

Cardiac Rehab. Home. www.homecareforyou.com. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

Cardiac Rehab. Home. www.homecareforyou.com. Do you suffer from a cardiac condition that is limiting your independence in household mobility? TM Nightingale Home Cardiac Rehab Do you suffer from a cardiac condition that is limiting your independence in household mobility? Such as, 1. A recent heart attack 2. A heart condition coronary artery

More information

The Cardiac Society of Australia and New Zealand

The Cardiac Society of Australia and New Zealand The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures

More information

Long-Term Effect of Dual Antiplatelet Treatment after Off-Pump Coronary Artery Bypass Grafting

Long-Term Effect of Dual Antiplatelet Treatment after Off-Pump Coronary Artery Bypass Grafting 366 2013 Wiley Periodicals, Inc. ORIGINAL ARTICLE Long-Term Effect of Dual Antiplatelet Treatment after Off-Pump Coronary Artery Bypass Grafting Jose Lopez, M.D.,* Carlos Morales, M.D.,* Pablo Avanzas,

More information

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease Erich Minar Medical University Vienna for the Task Force on the Diagnosis and Treatment of Peripheral

More information

REFLECTIONS: FORTY YEARS OF VASCULAR CARE

REFLECTIONS: FORTY YEARS OF VASCULAR CARE REFLECTIONS: FORTY YEARS OF VASCULAR CARE REFLECTIONS: FORTY YEARS OF VASCULAR CARE CEA AAA CEA AAA REDDY WHITEHOUSE ZELENOCK ZITO CEA AAA EVAR CEA CAS AAA VASCULAR SURGERY AS A SPECIALTY NON-INVASIVE

More information

Imaging of Thoracic Endovascular Stent-Grafts

Imaging of Thoracic Endovascular Stent-Grafts Imaging of Thoracic Endovascular Stent-Grafts Tariq Hameed, M.D. Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana Disclosures: No relevant financial

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

Public reporting improves healthcare. Jack Chen MBBS PhD MBA

Public reporting improves healthcare. Jack Chen MBBS PhD MBA Public reporting improves healthcare Jack Chen MBBS PhD MBA October 2010 BUREAU OF HEALTH INFORMATION PO Box 1770 Chatswood NSW 2057 Australia Telephone: +61 2 8644 2100 www.bhi.nsw.gov.au This work is

More information

Roux-en-Y Gastric Bypass

Roux-en-Y Gastric Bypass Roux-en-Y Gastric Bypass Restrictive and malabsorptive procedure Most frequently performed bariatric procedure in the US First done in 1967 Laparoscopic since 1993 75% EWL in 18-24 months 50% EWL is still

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10. FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.1056/NEJMSA1107913 Niteesh K. Choudhry, MD, PhD, 1 Jerry Avorn, MD, 1 Robert J. Glynn,

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

The Effects of Short-term Cardiac Rehabilitation on Post-CABG Patients Fitness

The Effects of Short-term Cardiac Rehabilitation on Post-CABG Patients Fitness 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 15 The Effects of Short-term Cardiac Rehabilitation on

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

Value-Based Purchasing

Value-Based Purchasing Emerging Topics in Healthcare Reform Value-Based Purchasing Janssen Pharmaceuticals, Inc. Value-Based Purchasing The Patient Protection and Affordable Care Act (ACA) established the Hospital Value-Based

More information

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo Acute Coronary Syndromes: oral antithrombotic therapy Focus on

More information

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,

More information

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:

More information

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Introduction... 2 Specialty Excellence Award Determination... 3 America s 100 Best Hospitals

More information

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1 Post CABG Rehabilitation i Ahmed Elkerdany Professor of Cardiac Surgery Ain Shams University 1 Definition Cardiac rehabilitation services are comprehensive, long-term programs involving : medical evaluation.

More information

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI)

Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) The American Society for Gastrointestinal Endoscopy PIVI on Endoscopic Bariatric Procedures (short form) Please see related White

More information

ABOUT XARELTO CLINICAL STUDIES

ABOUT XARELTO CLINICAL STUDIES ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

More information

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial

More information

Utilization Review Cardiac Rehabilitation Services: Underutilized

Utilization Review Cardiac Rehabilitation Services: Underutilized Utilization Review Cardiac Rehabilitation Services: Underutilized William J. Gill, MD Krannert Institute of Cardiology Indiana University School of Medicine Indianapolis, Indiana What is Cardiac Rehab?

More information

INFORMED CONSENT FOR SLEEVE GASTRECTOMY

INFORMED CONSENT FOR SLEEVE GASTRECTOMY INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.

More information

Scelte Antitrombotiche nelle SCA delle UTIC Italiane: Nuovi Dati dal Registro EYESHOT

Scelte Antitrombotiche nelle SCA delle UTIC Italiane: Nuovi Dati dal Registro EYESHOT CARDIOLUCCA 2014 HEART CELEBRATION Lucca, palazzo Ducale Sala Ademollo 27-29 Novembre 2014 Scelte Antitrombotiche nelle SCA delle UTIC Italiane: Nuovi Dati dal Registro EYESHOT Leonardo De Luca, MD, PhD,

More information

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY

GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY BLOOD CONSERVATION STRATEGIES IN CARDIAC SURGERY: MORE IS BETTER GUIDELINES IN ANTIPLATELET AND ANTICOAGULATION RX IN CARDIAC SURGERY DIMITRIOS V. AVGERINOS MD, PhD, FACS, FACC Department of Cardiac Surgery,

More information